Ubiquitin C-terminal hydrolase-L1 (UCH-L1) catalyses the hydrolysis of ubiquitin ester and amide mainly in neuronal cells. Recently it was proposed as a marker with a potential role in carcinogenesis. However, the molecular mechanism underlying the biological function of UCH-L1 in tumor cells is poorly understood. We found that UCH-L1 is highly expressed in non-small lung cancer cell line H157, having high invasive potential, and that the expression of UCH-L1 in tumor cells enhances their invasive potential in vitro and in vivo. UCH-L1 changes cell morphology by regulating cell adhesion through Akt-mediated pathway. Suppressing UCH-L1 expression by RNAi significantly suppressed the invasion in vitro and in vivo, and the activation of Akt and downstream mitogen activated protein kinases c-Jun N-terminal kinases and p38, but not ERK. In Akt-negative mutants, overexpression of UCH-L1 does not affect the invasion and migration capability of H157 cells. These results suggest that UCH-L1 is a key molecule to regulate tumor-cell invasion by upstream activation of Akt.
Introduction
Ubiquitin C-terminal hydrolase-L1 (UCH-L1) is a deubiquitylating enzyme (DUB; MW 24.8 kDa and pI 5.3) catalysing hydrolysis of C-terminal ubiquitin esters and amides, and peptide-ubiquitin amides in vitro. UCH-L1 is exclusively expressed in neurons, diffuse neuroendocrine systems and in testis/ovary, in contrast to its isozyme, UCH-L3, which is ubiquitously expressed in every tissue. UCH-L1 is one of the most abundant proteins in the brain. UCH-L1 is believed to play an important role in neurodegenerative diseases including Parkinson's disease, but its in vivo functions remain poorly understood (Lowe et al., 1990; Saigoh et al., 1999; Liu et al., 2002) .
UCH-L1 is not expressed in normal lung tissue, but is markedly expressed in primary lung cancer and lung cancer cell lines using gene expression method (Hibi et al., 1999) , as well as in invasive colorectal (Yamazaki et al., 2002) and pancreatic (Tezel et al., 2000) cancers. Another study (Brichory et al., 2001) reported that UCH-L1 is a tumor antigen eliciting a humoral immune response in lung cancer, and proposed UCH-L1 as a biomarker of lung cancer tumorigenesis. But the molecular mechanisms underlying the function of UCH-L1 remain unclear.
Cancer metastasis is a complex process involving local invasion by cancer cells, infiltration into vascular and lymphatic vessels, survival in the circulation, extravasation and growth at secondary sites. In this sequence of events, local invasion is the initial step (Honda et al., 1998) . The mechanism of cancer cell invasion is not well known but cell migration is clearly an important factor that regulates cancer cell invasion.
In this study, we found that UCH-L1 is significantly overexpressed in NSCLC H157 cells having high invasive potential. We, therefore, examined whether UCH-L1 is involved in the regulation of cell migration in tumor metastasis. Employing in vitro and in vivo studies, we found that the UCH-L1 increases cancer cell invasion by changing cell morphology and by modulating the upstream of Akt-mediated signaling pathway.
Results

UCH-L1 is specifically expressed in highly invasive lung cancer cells
In studies directed at understanding the mechanisms in cancer invasion, we attempted to identify, by proteomic analysis, the key proteins differentially expressed in lung cancer cell lines having various invasive potentials. We studied three cell lines, with different cell invasion capabilities as measured by in vitro Boyden chamber assay using the transwell coated with Matrigel ( Figure 1a) . The cell lines included WI38 cell line (VA-13 subclone 2RA, fibroblasts as normal cells) and two NSCLC cell lines, H358 (bronchioalveolar carcinoma) and H157 (squamous cell carcinoma). The order of invasive potential of these lines was: H157>WI38>H358. Proteins in the cell lysates were separated on two-dimensional gel electrophoresis, and protein expressions were quantitatively analysed by Figure 1 UCH-L1 is specifically expressed in the invasive H157 lung cancer cells. (a) WI38, H358 and H157 cells were subjected to a Matrigel invasion assay. The upper chamber of transwell was coated with 80 mg with Matrigel for 1 h at 37 1C. The lower chamber was filled with RPMI media containing 10% FBS. Cells that had migrated to the under surface of the membrane were stained with crystal violet (0.5% dissolved in 25% methanol) for 5 min and counted under a phase contrast microscope with a Â 10 objected lens. (b) The intracellular proteins of WI38, H358 and H157 cells were identified using prelabeling with [ tandem MS) ( Figure 1c ). The protein, whose expression increased with increasing invasive potential of the cells, was identified as UCH-L1 (accession number P09938). This was confirmed by western analysis using antibody against UCH-L1 (Figure 1d ), which also showed that UCH-L1 is highly overexpressed in H157 cells having high migration potential compared with H358 cells. We further examined the relationship between UCH-L1 expression and cancer in various cancer cell lines by western analysis. Expression of UCH-L1 was detected in H157, easily movable primary endothelial and smooth muscle cells, invasive melanoma and CaCO2 colon cancer cells shown in Figure 1d Figure 2 UCH-L1 modulates tumor-cell invasion. (a) H157 and WI38 cells were transiently transfected with pFlag-CMV2 vector or a plasmid expressing Flag-tagged UCH-L1 and pFlag-CMV2-UCH-L1 in a dose-dependent manner. After 24 h, same amount of cells (2.5 Â 10 3 cells) were seeded on the upper chamber of transwell coated with Matrigel. After 24 h, the number of cells migrated down the lower chamber were counted. Symbol (*) is Po0.05. (b) HeLa cells were transiently transfected with a plasmid expressing myc-tagged wild type UCH-L1, pcDNA3.1-UCH-L1(wt)-myc or myc-tagged mutant UCH-L1, pcDNA3.1-UCH-L1(C90S)-myc in a dose-dependent manner. Data were shown as the mean number of migrated cells ± s.d. from three independent experiments. Symbols (* and **) are Po0.05. UCH-L1, Ubiquitin C-terminal hydrolase-L1.
UCH-L1 is a key regulator of tumor cell invasion and metastasis HJ Kim et al and non-invasive breast (MCF7) cancer cells (Supplementary Figure S1 ). These results suggest that UCH-L1 possibly plays a role in cancer cell invasion.
UCH-L1 is a key regulator of cell migration
We next examined whether UCH-L1 is a cause or the result of cancer cell invasion. We measured the effects of various doses of exogenously overexpressed UCH-L1 on cell migration in lung fibroblast WI38 and cervical cancer cell line (HeLa) by in vitro Boyden chamber assay using the transwell coated with Matrigel. WI38 cells having low endogenous UCH-L1 and low invasive potential, were transfected with exogenous pFlag-UCH-L1, and cell migrations were examined. As shown in Figure 2a , in vitro cell migrations depended on the amount of transfected UCH-L1 and significantly increased in a dose-dependent manner. We further confirmed this effect in HeLa cells, which were densely methylated at the promoter region of Uchl1 (Bittencourt Rosas et al., 2001) , having no endogenous UCH-L1 (Figure 2b ). The overexpression of UCH-L1 significantly increased invasion in a dose-dependent manner in both WI38 and HeLa cells (Figures 2a and b) . However, the overexpression of active site mutant UCH-L1 (C90S) not having enzymatic activity did not affect the cell migration (Figure 2b ). This suggests that enzymatic activity of UCH-L1 plays a key role in cell invasion and in tumor-cell metastasis.
Silencing Uchl1 gene diminishes the invasive capability of H157 lung cancer cells To confirm that UCH-L1 overexpression enhances cell invasion, we examined the loss of function effect of UCH-L1 by knockdown using lentivirus-based shRNA UCH-L1 is a key regulator of tumor cell invasion and metastasis HJ Kim et al on cell invasion in H157 cells. We used lentivirus-based vector that expresses RNAi-inducing shRNAs under the control of U6 promoter to suppress UCH-L1 expression in H157 cells. This vector was engineered to coexpress enhanced green fluorescent protein as a reporter gene, permitting infected cells to be monitored by flow cytometry ( Figure 3a ). As the target sequence for UCH-L1 RNAi, we used the sequence used by earlier report (Liu et al., 2003) . As shown in Figure 3b , the expression of UCH-L1 was reduced in H157 stable cells expressing UCH-L1-specific RNAi compared with scrambled RNAi as determined by western blot analysis with anti-UCH-L1 antibody. Infection of these cells was quite efficient (>98%), as gauged by expression of green fluorescent protein, and the accompanying reduction in UCH-L1 expression ( Figure 3b ). The invasion and migration capabilities of H157 cells, after suppressing UCH-L1 expression with specific RNAi, were ) expressing control RNAi or UCH-L1-specific RNAi were injected intravenously into the tail vein of male BALB C/nude mice. After 2 weeks of intravenous injection, the lung was extirpated and the black spherical B16F10 colonies were counted. Two representatives per each set are shown. Metastasized colonies into lung were shown mostly in mice injected with control B16F10 cells. (e) Data were shown as the mean number of colony ± s.d. from three mice per each set. Symbol (*) is Po0.01. GFP, green fluorescent protein; UCH-L1, Ubiquitin C-terminal hydrolase-L1.
UCH-L1 is a key regulator of tumor cell invasion and metastasis HJ Kim et al monitored in vitro using transwell chamber coated with Matrigel and migration assay, respectively. As shown in Figure 3c , the invasiveness of UCH-L1 knockdown cells significantly decreased compared with control cells expressing scrambled RNAi. This decrease was further confirmed in another assay in which cells were induced to migrate by physical wounding of cells plated on cell culture plates. Figure 3d and Supplementary Figure S2 shows that wound healing after 5 and 71 h was inhibited in UCH-L1-knockdown H157 stable cells compared with control cells. These results confirm that knockdown of UCH-L1 expression in invasive H157 cells reduced their capacity for cell invasion and migration, and confirm that UCH-L1 is a key regulator of cell invasion.
Decreased UCH-L1 expression suppresses pulmonary metastasis of B16F10 cells We next examined the effect of UCH-L1 on in vivo metastasis, employing an experimental mouse model of metastasis. In vivo metastasis was measured in mouse by counting the black melanoma spherical colonies in the lung generated after intravenously injecting highly metastatic melanoma B16F10 cells. As shown in Figure 4a , UCH-L1 was highly expressed in invasive melanoma B16F10 cells, but to a lower degree than in H157 cells. We infected the highly metastatic B16F10 melanoma cells with either scrambled RNAi as a control or with UCH-L1-specific RNAi expressing lentivirus. We injected control and knockdown cells into the tail veins of BALB/C nude mice, and analysed the extents of lung metastasis after 2 weeks. UCH-L1 expression was reduced by up to 60% in B16F10 cells expressing UCH-L1-specific RNAi, compared those infected with scrambled RNAi, as determined by western analysis (Figure 4b ). Before injection, we confirmed the knockdown of UCH-L1 by monitoring endogenous green fluorescent protein expression in B16F10 using flow cytometry after complete selection with Zeocin ( Figure 4c) . In vivo metastasis, measured 2 weeks after injections, significantly decreased after injection of UCH-L1 knockdown cells as shown in Figure 4d , as evidenced by the fact that there were only 28.7 ± 2.9 colonies (Figure 4e ). In contrast, there was significant metastasis after injection of control B16F10 cells expressing scrambled RNAi (350±41 metastatic colonies per lung). These findings are consistent with in vitro observations that UCH-L1 is a key regulator of invasion, and suggest that it UCH-L1 is a key regulator of tumor cell invasion and metastasis HJ Kim et al may be possible to inhibit cancer invasion and metastasis by suppressing UCH-L1.
UCH-L1 regulates cell morphology, but not cell cycles in H157 cells
To understand how UCH-L1 regulates cell invasion, we examined the effects of UCH-L1 expression on cell morphology and cell cycles. Changes in cell morphology are induced by several events. Directed cell migration requires cell polarization and adhesion turnover, phenomena in which actin cytoskeleton and microtubules play critical roles (Yamana et al., 2006) . H157 cells infected with UCH-L1 RNAi lentivirus were monitored for 72 h after seeding at low density (1 Â 10 4 cells) on 60 mm cell culture dish. We observed morphological changes in H157 cells infected with scrambled or UCH-L1-specific RNAi. As shown in Figure 5a , H157 cells with reduced UCH-L1 expression had round shape, lost their polarity (Supplementary Figure S2b) and showed decreased cell spreading, whereas H157 cells infected with control lentivirus showed cell spreading and cellcell contact, just like uninfected cells. This finding is in agreement with an earlier report (Osaka et al., 2003) that UCH-L1 spatially mediates and enhances neurogenesis in embryonic brain by regulating progenitor cell morphology, and suggests that the ability of UCH-L1 to regulate the morphology of H157 cells is related to their invasive capability.
Earlier work (Liu et al., 2003) reported, using [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) assays, that the expression levels of UCH-L1 in H1299 cells inversely correlate with cell proliferation. Another (Caballero et al., 2002) identified JAB1, a Jun activation domain binding protein that can bind to p27Kip1, as interacting protein of UCH-L1 using yeast two-hybrid system. p27Kip1, a cyclin-dependent kinase inhibitor, regulates progression from G1 into S phase of the cell cycle by binding and inhibiting cyclin/cdks (Polyak et al., 1994; Toyoshima and Hunter, 1994) . Based on this report, and our own finding on the effect of UCH-L1 on cell morphology, we hypothesized that UCH-L1 might be involved in the regulation of cell cycle. To determine whether the change of morphology of H157 cells expressing UCH-L1 RNAi into round shape is a result of their growth arrest, we examined the effect of UCH-L1 expression on cell cycle regulation. We repeatedly (nine times) analysed cell cycle by fluorescence-activated cell sorting after staining propidium iodide. H157 cells expressing scrambled or UCH-L1-specific RNAi were stained with propidium iodide followed by analysis of DNA content using fluorescence-activated cell sorting. In contrast to an earlier report (Liu et al., 2003) , the level of UCH-L1 expression as a soluble fraction (Supplementary Figure S3) in H157 cells did not affect any specific phase of cell cycle (Figure 5b, Supplementary Figure S4) ; the round shape was observed after UCH-L1 knockdown (Figure 5a ). There were no discernible differences in DNA contents in G1, S and G2 phases and cell number (data not shown). These results suggest that the expression level of UCH-L1 in H157 affects cell invasion and morphology, but not cell cycle. The effect of UCH-L1 on cell cycle can be discernible depending on the cell types.
To determine how UCH-L1 causes changes in cell morphology, we examined the effect of UCH-L1 expression on cell morphology and focal adhesion. When the non-invasive, round shaped NSCLC H358 cells, not expressing UCH-L1, were transiently transfected with control pFlag and pFlag-UCH-L1 vector, the overexpression of exogenous UCH-L1 in H358 cells induced significant morphological changes including polarity increase and cell spreading (Figure 6a ). To determine whether focal adhesion plays any role in UCH-L1 induced morphological changes, we assessed (a) H358 cells were transiently transfected with pFlag-CMV2 vector or pFlag-CMV2-UCH-L1. These cells were incubated with phalloidin fluorescein isothiocyanate for actin staining and with propidium iodide for nuclear staining. (b) H157 cells expressing scrambled RNAi or UCH-L1-specific RNAi were grown on the coverslips. After 24 h, the cells were stained with antibody to paxillin followed by Alexa Fluor 568 conjugated secondary antibodies. Alexa Fluor 568 phalloidin was used for F-actin staining. GFP image was obtained from the endogenous GFP. The actin and paxillin images of one representative field for each sample are shown. GFP, green fluorescent protein; UCH-L1, Ubiquitin Cterminal hydrolase-L1.
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paxillin, a marker of focal adhesion, in UCH-L1 knockdown H157 cells. Highly invasive H157 cells were infected with either UCH-L1-specific RNAi or control scrambled RNAi, and examined for the presence of actin and paxillin using confocal microscopy. As shown in Figure 6b , actin stress fibers significantly collapsed and paxillin disappeared in UCH-L1 knockdown cells, compared with controls. This indicates that a significant disruption in focal adhesion occurred in UCH-L1 knockdown H157 cells, and that UCH-L1 is possibly acting on the signaling pathway for the activation of paxillin that is essential for cell migration, and is localized in focal adhesion sites after phosphorylation by c-Jun N-terminal kinases (JNK) (Huang et al., 2004) . Additional studies of the mitogen activated protein kinase (MAPK) cascade are necessary to determine the site of action of UCH-L1.
UCH-L1 affects EGF-induced signaling pathway on JNK and p38 MAPK, upstream of Akt
To understand whether UCH-L1 is involved in metastatic cascades in UCH-L1 expressing lung cancer cells, we measured Akt and MAPK activations in response to epidermal growth factor (EGF) in control and UCH-L1 knockdown cells. The Akt and MAPKs family including extracellular signal-regulated kinase (ERK), JNK and p38 MAPK can be activated downstream of the growth factor receptor kinases. H157 cells expressing control or UCH-L1-specific RNAi were treated with EGF (20 ng/ ml) for various times (0, 5, 10, 20, 40, 80 and 160 min) , and the kinetics of Akt and MAPK activation were observed. As shown in Figures 7a and b , Akt, JNK and p38 were deactivated in cells expressing UCH-L1-specific RNAi more markedly and rapidly than in cells (0, 5, 10, 20, 40, 80 and 160 min) . At the indicated time points, EGF-treated cells were lysated with gel sample buffer. The same amount of proteins were separated on 11% SDS-PAGE and analysed by western blotting using antibodies to phosphorylated ERK (P-ERK), phosphorylated p38 (P-p38), phosphorylated Akt (P-Akt) and phosphorylated JNK (P-JNK). (c) HeLa cells were transiently transfected with pFlag-CMV2 (2 mg) vector or Flag-UCH-L1 (2 mg), and then infected with control adenovirus (null vector) or adenovirus expressing hemagglutinin-tagged inactive phosphorylation mutant Akt (Ade-Akt-AA). And same amount of cells were loaded on a Matrigel pre-coated invasion chamber and incubated with serum-free media at 37 1C for 24 h. The non-migrating cells after incubation were removed, and migrating cells stained with crystal violet and destained with dd-H 2 0. The migrating cells were counted using a microscope. Data were shown as the mean number of migrated cells ± s.d. from three independent experiments. Symbol (*) is that the means are not significantly different at the 0.05 level. Symbol (**) is Po0.05. JNK, c-Jun N-terminal kinases; UCH-L1, Ubiquitin C-terminal hydrolase-L1.
UCH-L1 is a key regulator of tumor cell invasion and metastasis HJ Kim et al expressing scrambled RNAi. There was no discernible difference in ERK MAPK activations between control and UCH-L1 RNAi-infected H157 cells. Activation of Akt, which influences cell survival by inhibiting apoptotic processes, was correlated with the UCH-L1 expression (Figure 7b ). These results suggest that EGFinduced activations of Akt, JNK and p38 MAPKs are regulated by UCH-L1 in H157 cells, and that UCH-L1 plays a role in the signaling cascade of Akt and MAPK. EGF causes a rapid, transient activation of propidium iodide-3-kinase and of Akt, which activates MAPK cascade proteins including JNK and p38 MAPK. To determine whether UCH-L1 acts upstream or downstream of Akt, we examined cell migration in UCH-L1 overexpressing cells infected with Akt-negative mutants. HeLa cells overexpressing control Flag and Flag-UCH-L1 were infected with adenoviruses containing control or Akt-negative mutants. As shown in Figure 7c , overexpression of UCH-L1 increased cell migration, and this effect of UCH-L1 on cell migration was abrogated in Akt negative mutants in a dose-dependent manner. These findings are consistent with the hypothesis that UCH-L1 affects cell migration upstream of Akt/MAPK cascade.
Discussion
The present study shows that overexpression of UCH-L1 in cancer cells enhances their invasive potential and tumor metastasis. We believe that UCH-L1 plays a role in the regulation of cell invasion by modulating cell morphologies through Akt activation. This is a first report identifying UCH-L1 as an important new molecule involved in cancer metastasis.
Overexpression of UCH-L1 upregulates cell invasion in vitro. Reduction in the expression of UCH-L1 using UCH-L1 RNAi lentivirus, decreased cell invasion in vitro in H157 cells and significantly reduced cancer metastasis induced by highly invasive B16F10 mouse melamona cells in an animal model. Recent report (Liu et al., 2003) demonstrated that small molecule inhibitors of UCH-L1 have pro-proliferative activity in H1299 lung cancer cells. They suggest that suppression of UCH-L1 by small molecules induces tumor progression, caused by the UCH-L1 unique ligase activity (Liu et al., 2003) . However, when we examined the effect of UCH-L1 expression on cell cycle and proliferation in H157 cells (Figure 5b) , we found that UCH-L1 is involved in cell invasion processes, rather than in proliferation in lung cancer cells.
Metastasis by definition, is the spread of cancer from a primary site to distant organs. This involves the coordination of several signal-transduction pathways that allow cancer cells to proliferate, remodel their surrounding environment, invade to distant sites and re-establish the tumor (Reddy et al., 2003) . Recently, many studies have shown that MAPK plays a major role in inducing proteolytic enzymes that degrade the basement membrane, in enhancing cell migration, initiating several pro-survival genes and maintaining growth (Yoeli-Lerner and Toker, 2006) . Activated MAPK pathway has been detected in many human tumors including carcinomas of the breast, colon, kidney and lung, suggesting that MAPK may play a major role in tumor progression and metastasis. However, no MAPK signaling pathway has been identified in UCH-L1-induced migration of cells. To determine whether the expression level of UCH-L1 affects EGF-induced activation of Akt and MAPKs, we examined the inhibition of EGF-induced activation of Akt and MAPKs in UCH-L1 RNAi-infected H157 cells. Akt, JNK and p38 were less activated in cells expressing UCH-L1-specific RNAi than in cells expressing scrambled RNAi. However, there was no discernible difference in ERK MAPK activations between control and UCH-L1 RNAi-infected H157 cells. Cell migration increase was not observed in cells overexpressing UCH-L1 infected with Akt negative mutants. This indicates that UCH-L1 increases cell migration by modulating Akt activation.
Reduction in the expression of UCH-L1 in H157 cells by treatment with specific RNAi decreased their migration capability and changed their morphology without affecting cell cycle. The targets modulated by UCH-L1 upstream of Akt, can be propidium iodide-3-kinase, and small G proteins consisting of the Rho, Rac and Cdc42 subfamilies. Members of the Rho family have been recognized as key regulators of signal transduction pathways that mediate changes in the actin cytoskeleton required for transformation (Huang et al., 2004) . However, the balance among RhoA, Rac and Cdc42 activities determines whether a given cell remains stationary or becomes migratory (Diebold et al., 2004; Wojciak-Stothard et al., 2005) . We found that the decreased UCH-L1 expression caused by RNAi results in disruption of focal adhesion. This suggests that UCH-L1 is an upstream regulator of Akt. Recent study (Gong et al., 2006) reported that UCH-L1 as a soluble form is required for synaptic and cognitive function, and can induce the restoration of the Abinduced damage through PKA-CREB pathway. Our results are well agreed with this earlier work. Further studies should be done to understand how UCH-L1 can regulate the Akt activation.
In summary, this study shows for the first time that UCH-L1 plays a key role in the regulation of cell invasion in lung cancer, melanoma and in cancer metastasis, and that UCH-L1 modulates cell morphology by regulating the upstream Akt and influencing cell migration. Further studies directed at identifying elements involved in the regulation of the upstream Akt by UCH-L1, may lead to interventions that inhibit the cancer metastasis.
Materials and methods
Cell culture and antibodies Human WI38 (normal lung cells), NSCLC H157 and NSCLC H358 cells were grown in classical media developed at Roswell UCH-L1 is a key regulator of tumor cell invasion and metastasis HJ Kim et al Park Memorial Institute (RPMI 1640) supplemented with 10% fetal bovine serum (Gibco BRL, NY, USA) at 37 1C and 5% CO 2 . Mouse melanoma B16F10 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum at 37 1C and 5% CO 2 . Polyclonal anti-UCH-L1 (AB1761) antibody was obtained from Chemicon (CA, USA). Phospho-Akt, phospho-JNK, phospho-p38 and phospho-ERK antibodies were obtained from Cell Signaling Technology (MA, USA).
Plasmids
Human UCH-L1 was subcloned into pFlag-CMV-2 vector (Sigma-Aldrich Biotechnology, LP, USA). pFlag-CMV-2/ UCH-L1 (1-223) constructs were prepared by PCR using the sense primer 5 0 -CCCAAGCTTATGCAGCTCAAGCCG-3 0 and antisense primer 5 0 -ACGCGTCGACTTAGGCTGCCT TGC-3 0 .
Transient transfection H157, H358, WI38 and HeLa cells were transfected with expression plasmids using Lipofectamine reagent (Invitrogen, CA, USA). Cells were seeded on cell culture plates a day before transfection with 12 mg of expression plasmids and 30 ml Lipofectamine reagent in Opti-MEM solution (Gibco BRL, NY, USA). The medium was changed with fresh 10% fetal bovine serum containing RPMI 5 h after transfection, and cultured for an additional 19 h before harvesting or further treatments.
shRNA expressing lentiviral vectors shRNA lentiviral vectors for targeting human and mouse UCH-L1 genes were constructed by inserting synthetic double stranded oligonucleotides (Liu et al., 2003) into EcoRI-XbaI restriction enzyme sites of shLenti1.1 lentiviral vector. The shLenti1.1 lentiviral vector (Macrogen, Seoul, Korea) was designed to produce shRNAs from U6 promoter and to express eGFP-Zeocin fusion protein from hCMV promoter. As control vectors, scrambled sequences (AATCGCA TAGCGTATGCCGTT) were inserted into the shLenti 1.1 lentiviral vector as described above.
Expression analysis and flow cytometry H157 and B16F10 cells were infected with control or UCH-L1 RNAi lentivirus. After Zeocin selection, green fluorescence protein-coexpressing cells were harvested with phosphatebuffered saline (PBS), and fluorescence data were acquired with a fluorescence-activated cell sorting flow cytometer (BD Bioscience, NJ, USA) and analysed with the Cellquest Software.
Immunoblotting
Proteins were immediately transferred onto PVDF membrane and separated by SDS-PAGE (for 2 h at 200 mA) on ice. Membrane was blocked with 3% bovine serum albumin in PBS containing 0.1% Tween-20 for 2 h at room temperature and sequentially incubated with each antibody diluted 1:1000 in PBS containing B3-5% bovine serum albumin for 2 h at room temperature. After washing three times with PBS containing 0.1% Tween-20, the membrane was incubated with second antibody, goat anti-mouse antibody or goat anti-rabbit antibody, diluted 1:2000 in PBS containing 0.1% Tween-20, and then washed three times with PBS containing 0.1% Tween-20 for 10 min. Identification of the immune complexes was performed using Amersham Biosciences ECL kit (NJ, USA) and LAS-3000s (Fuji photo film Co., Japan).
Cell migration assay
This assay was performed using a 24-well chemotaxis chamber transwell (Corning, NY, USA). The upper chamber of transwell was coated with 50 mg Matrigel (Matrigel basement membrane matrix, BD Bioscience, NJ, USA) for 1 h at 37 1C and then placed into 24-well chambers. The lower chamber was filled with RPMI media containing 10% fetal bovine serum. Cells transfected with pFlag-CMV2 vector or pFlag-CMV2-UCH-L1 were seeded into the upper chamber (B0.5-1 Â 10 4 cells in 150 ml), and incubated for 24 h at 37 1C. The non-migrating cells were removed from the upper side of the filters with cotton balls. The migrating cells were stained with crystal violet (0.5% w/v crystal violet and 25% methanol) and counted at 100-fold magnification using a microscope.
Confocal microscopy
Cells were grown on the Secureslip (Gracebiolab, OR, USA) cell culture cover slip to 70% confluence and washed with cold PBS. Cells were gently washed with Hanks balanced salt solution (HBSS), and fixed with 4% paraformaldehyde in HBSS for 10 min at room temperature. After washing with HBSS, the cells were permeabilized by incubation with 0.1% Triton X-100 in HBSS for 15 min at room temperature. After the HBSS wash, the cover slip was moved to another solution and treated with 3% bovine serum albumin, 0.2% Tween-20 and 0.2% gelatin in HBSS for 1 h at room temperature to block non-specific protein adsorption. Mouse monoclonal anti-Flag antibody was diluted 1:500 for Flag-tagged proteins and Alexa Fluor 568 conjugated phalloidin antibody (Molecular Probes, OR, USA) for F-actin staining, was diluted 1:100 in HBSS containing 1% bovine serum albumin and 1% sucrose for 1 h at 37 1C. After three washings with HBSS, cells were stained for 30 min at 37 1C with Alexa Fluor 488 or 568 conjugated goat anti-mouse IgG (Molecular Probes, OR, USA) diluted 1:20. Cells were photographed at Â 40 magnification with a fluorescence confocal microscope (LSM510, Zeiss, Germany). Cell morphology was examined under an inverted microscope (Zeiss, Germany) at Â 40 magnification.
Experimental metastasis
Experimental metastasis was performed as described previously (Kurisu et al., 2005) . Briefly, B16F10 cells were infected twice with control or UCH-L1 RNAi lentivirus, and the infected cells were selected with 12.5 mg/ml of Zeocin (Invitrogen, CA, USA) for 14 days, trypsinized and suspended in PBS. Cells (1.0 Â 10 6 ) were injected intravenously into the tail vein of male BALB C/nude mice (Jung-Ang Lab. Animal, Inc., Seoul, Korea). After 2 weeks of intravenous injection, the lung was extirpated and the black spherical B16F10 colonies were counted. The image of colony on the lung surface was microphotographed using the MZFL III (Leica Microsystems, Germany).
Samples for mass spectrometric analysis Protein samples were separated with two-dimensional gel electrophoresis (Song et al., 2005) . The gel spots were digested with trypsin and sequenced by nano flow reversed-phased nanoLC-ESI-q-TOF tandem MS (Q-tof Ultima global, Waters Co., UK) as described previously (Kim et al., 2007) .
